AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 110 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $2,437,000 | -25.9% | 40,782 | -39.7% | 0.44% | -0.2% |
| Q3 2017 | $3,289,000 | -14.2% | 67,668 | -7.2% | 0.44% | -31.0% |
| Q2 2017 | $3,832,000 | -9.1% | 72,930 | -21.5% | 0.63% | -4.7% |
| Q1 2017 | $4,216,000 | +10.5% | 92,963 | -7.7% | 0.66% | +31.0% |
| Q4 2016 | $3,814,000 | -19.1% | 100,759 | -19.3% | 0.51% | -19.9% |
| Q3 2016 | $4,715,000 | +30.8% | 124,932 | +8.6% | 0.63% | +52.2% |
| Q1 2015 | $3,605,000 | -4.9% | 115,038 | -11.4% | 0.42% | -21.4% |
| Q4 2014 | $3,789,000 | +98.0% | 129,816 | +40.4% | 0.53% | +36.0% |
| Q3 2014 | $1,914,000 | +160.1% | 92,489 | +211.1% | 0.39% | +177.9% |
| Q2 2014 | $736,000 | – | 29,730 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LEVIN CAPITAL STRATEGIES, L.P. | 1,373,542 | $15,658,000 | 1.56% |
| DAFNA Capital Management LLC | 289,040 | $3,295,000 | 0.87% |
| Integral Health Asset Management, LLC | 250,000 | $2,850,000 | 0.82% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 193,266 | $2,203,000 | 0.80% |
| PFM Health Sciences, LP | 2,182,684 | $24,883,000 | 0.73% |
| DCF Advisers, LLC | 136,501 | $1,556,000 | 0.69% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,977,020 | $33,938,000 | 0.66% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $3,532,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 750,000 | $8,550,000 | 0.60% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,232,600 | $14,052,000 | 0.52% |